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DObjective: Quality of life has been shown to be influenced by aortic valve replacement, particularly in younger
patients. Aortic valve repair is a recent alternative to replacement. We investigated quality of life and anxiety and
depression after aortic valve repair and compared with 2 established replacement alternatives, mechanical valve
and pulmonary autograft.
Methods: In a cross-sectional study, 166 patients (age, 18–45 years) were studied after isolated elective aortic
valve surgery. They had undergone aortic valve repair (group I, n ¼ 86), replacement with mechanical prosthe-
sis (group II, n ¼ 41), or pulmonary autograft (group III, n ¼ 39). Assessment was performed by Short Form
Health Survey, Hospital Anxiety and Depression Scale, Cardiac Anxiety Questionnaire, and valve-specific
questions.
Results: In Short Form Health Survey, groups I and III revealed similar or identical scores better than group II in
physical functioning (P¼ .02), general health (P¼ .03), and mental health (P¼ .05). No differences were found
in Hospital Anxiety and Depression Scale score. In cardiac anxiety, there was less heart-focused attention in
groups I and III than in group II (P ¼ .043, P ¼ .053). In response to valve-specific questions, there were no
differences between groups I and III. Interestingly, fear of reoperation was identical in all 3 groups.
Conclusions: In young patients after aortic valve surgery quality of life is influenced by type of operation.
Although differences are limited, aortic valve reconstruction and pulmonary autograft replacement lead to
less long-term alteration from normal values. (J Thorac Cardiovasc Surg 2011;142:e19-24)Aortic valve replacement has become the standard of care
for hemodynamically severe regurgitation or stenosis of
the aortic valve.1 Mechanical and biologic substitutes result
in good hemodynamic relief but expose the patient to valve-
related complications at a clinically relevant incidence.2,3
The pulmonary autograft is a possible alternative,
particularly for young patients or those who wish to avoid
long-term anticoagulation.4 Recent data suggest that the au-
tograft is associated with a low incidence of valve-related
complications.5 In the past decade, reconstructive surgery
has become a new alternative in surgical treatment of aortic
valve regurgitation, both for dilated and for normal roots.6-10
Currently, recommendations for a specific aortic valve
procedure or substitute are based primarily on postoperative
survival data.1 This assumes that the primary consideration
of the patient is survival and not the incidence of valve-
related complications. The relative incidence of complica-
tions and a more individualized estimate of life expectancye Department of Thoracic and Cardiovascular Surgery,a University Hospital
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The Journal of Thoracic and Cahave only recently been studied and recommended as guide
for therapeutic decisions.11
In our experience, numerous discussions with patients
before and after aortic valve operations have shown a gen-
eral trend toward strongly considering the incidence of
valve-related complications and also quality of life (QoL)
when choosing the procedure for their aortic valves.
The effect of different aortic valve operations on postoper-
ative QoL has been studied only more recently. It has been
demonstrated that aortic valve replacement markedly im-
proves QoL relative to the preoperative status.12,13 In
several studies, no differences were found between biologic
and mechanical prostheses.12,13 A comparison between
QoL after implantation of a pulmonary autograft and after
mechanical aortic valve replacement revealed significantly
higher scores in physical QoL after autograft replacement.14
As yet there are no published data comparing QoL after
aortic valve repair with that after more established alterna-
tives. It may be assumed that patients would intuitively pre-
fer preservation of their own valve over replacement with
material from a foreign body; however, any informed con-
sent must include the fact that the current replacement op-
tions allow a 20-year prognosis, whereas the scarcity of
long-term data on aortic valve repair allow at best a 10-
year prognosis. In addition, the durability of repair has
not always been ideal,15,16 and this knowledge may have
a negative effect on QoL. On the other hand, aortic valve
reconstruction has been shown to be associated with a lowrdiovascular Surgery c Volume 142, Number 2 e19
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Dincidence of valve-related complications,17,18 which may
contribute to a positive attitude toward this procedure.
We therefore investigated the QoL and the impact of
heart-related and general anxiety and depression after aor-
tic valve repair and compared them with those of 2 estab-
lished alternatives for the young patient, replacement
with a mechanical valve and replacement with a pulmonary
autograft. Our hypothesis was that the absence of anticoa-
gulation and the low incidence of valve-related complica-
tions after repair should result in a QoL comparable to
that after pulmonary autograft.
MATERIALS AND METHODS
Patients
In a clinical cross-sectional, study patients were studied who had under-
gone aortic valve surgery during a 10-year interval (1997–2007) and were
alive at the time of the investigation. To minimize the effect of patient age
on QoL, only patients who were older than 18 and younger than 45 years
were included. Patients were excluded if more than the aortic valve re-
quired surgical treatment (eg, ascending aorta, mitral valve) or if they re-
quired treatment for active endocarditis. To minimize potential effects of
communication problems, only patients who spoke and understood Ger-
man fluently were included.
Secondary exclusion criteria for matching were left ventricular ejection
fraction less than 50%, more than minimal residual aortic regurgitation,
postoperative New York Heart Association (NYHA) class greater than I,
the presence of a psychiatric disorder, and dialysis-dependent renal failure.
These criteria led to exclusion of 4 patients who were in NYHA class II in
conjunction with depressed left ventricular function; these patients also
had grade II aortic regurgitation. In addition, patients with other cardiac co-
morbidity (eg, mitral regurgitation requiring surgery) and active endocarditis
as indication for surgery were excluded (n ¼ 13) to avoid interference be-
tween type of operation and other physical limitations, such as previous
stroke. None of the patients underwent reoperation after the index procedure
for which theywere studied.A total of 6 patients were included for whom the
index operation was a reoperation. Three patients underwent biologic aortic
valve replacement during the study period; these patients were not included.
Only patients who gave their consent to the study and the publication of
the results in anonymized fashion were included, and the institutional re-
view board gave its approval for this investigation. Twenty-five of 191 pa-
tients refused to participate, and the remaining 166 (positive response rate
87%) are considered in this study. Of these, 86 hade undergone aortic valve
repair (group I), 41 had undergone valve replacement with a mechanical
prosthesis (group II), and 39 had undergone replacement with a pulmonary
autograft (group III). Patients in group II were treated with warfarin so-
dium–based anticoagulation; patient in groups I and III received aspirin
(100 mg/d) for 6 weeks and no anticoagulation thereafter.
Instruments and Assessment
All patients were contacted directly regarding participation in the study
during an outpatient visit or by telephone. They were given the question-
naires and asked to return them by mail.e20 The Journal of Thoracic and Cardiovascular SurgAssessment of health-related QoL was performed with the German ver-
sion of the Short Form Health Survey (SF-36).19 The 36 items were ana-
lyzed in 8 subscales (physical functioning, physical role, bodily pain,
general health, vitality, social functioning, emotional role, and mental
health).
Anxiety and depression were analyzed with the German version of the
Hospital Anxiety and Depression Scale.20 The 14 items were those in-
cluded in the 2 dimensions of anxiety and depression.
The patients were also assessed with the German version of the Cardiac
Anxiety Questionnaire,21 consisting of 17 questions in 3 scales: fear (re-
garding the heart), avoidance (cardioprotective behavior, avoidance of
physical exertion), and attention (awareness of heart functioning and heart-
beat). Finally, valve-specific questions were asked, as published by Per-
chinsky and colleagues.13
In addition, preoperative hemodynamic data (type and severity of aortic
valve lesion, left ventricular ejection fraction, NYHA class, left ventricular
dimensions, transvalvular pressure gradients, comorbidity) were collected
and analyzed. Postoperative cardiac data including NYHA class, transvalv-
ular gradients, degree of aortic regurgitation, and left ventricular function
and dimensions were collected and analyzed. Personal data included age,
sex, and schooling.
Statistical Analysis
Categoric variables were described as absolute and relative frequencies
and continuous variables as mean SD. The comparisons between groups
were performed by Kruskal–Wallis test for categoric variables and by 2-
sided analysis of variance for continuous variables. The SPSS software
package version 16.0 (SPSS Inc, an IBM Company, Chicago, Ill) was used.
RESULTS
Clinical Data
There were no significant differences between the groups
with regard to sex distribution (Table 1), preoperative
NYHA class, or parameters of left ventricular function.
There was a significantly higher proportion of patients
with preoperative aortic regurgitation in group I (86.2%
vs 65% in group II and 62.1% in group III, P¼ .001). Sim-
ilarly, there was no difference between the groups with
regard to postoperative clinical or cardiac parameters.
There was a higher proportion of individuals with college
education in group I (40.2% vs 20.5% in group II and
17.9% in group III, P ¼ .023).
In group I, the interval between operation and survey date
was 2.46 2.16 years. In groups II and III, this interval was
significantly longer, at 6.48  2.38 years and 6.07  2.59
years, respectively.
Patients in group I were significantly younger at the time
of the investigation, resulting from both slightly younger
age at surgery (P ¼ .114) and shorter follow-up (P ¼ .08).
To correct for the nonsignificant difference in follow-up,
all analyses were repeated for a subgroup of patients with
a follow-up of 3 to 7 years. This cohort included 71 patients
(group I, n ¼ 27; group II, n ¼ 22; group III, n ¼ 22).
Health-Related QoL (SF-36)
In physical functioning, group I had significantly higher
scores than group II (88.39 vs 80.37, P ¼ .022), whereas
the difference between groups I and III (82.56) was notery c August 2011
TABLE 1. Patient characteristics
No.
Sex
(male/female)
Age at operation
(y, mean ± SD)
Age at survey
(y, mean ± SD)
Group I 87 63:24 38  6 40  6
Group II 40 35:5 40  7 46  7
Group III 39 27:12 40  7 46  7
Group I, Patients with valve repair; Group II, patients after mechanical aortic valve
replacement; Group III, patients after Ross procedure.
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eters were not constant but varied in relation to time elapsed
since the operation. This effect was particularly apparent for
the physical sum scale (Figure 1). We therefore performed
an additional analysis in which only a subgroup of patients
for whom the follow-up ranged from 3 to 7 years was stud-
ied. In this subgroup with more defined follow-up duration,
physical functioning after repair (group I, 92.50) was signif-
icantly higher than that after mechanical replacement
(group II, 80.9; P ¼ .01) and was comparable to that in
group III (85.0, P ¼ .089).
There were no difference among the 3 groups in physical
role. In bodily pain, there were identical scores in groups I
and III, with a trend toward higher scores than in group II, al-
though the differences were not significant (Table 2). Only in
the subgroup of patients with a follow-up of 3 to 7 years did
patients who had undergone repair reveal significantly less
pain than those who had undergone mechanical replacement
(86.8 vs 72.54, P ¼ .037). With regard to general health,
there was a significantly higher score in group I (66.21)
than in group II (57.67, P ¼ .029), whereas the difference
between groups II and III (64.86) was not significant.
In social functioning, comparable data were obtained in
all 3 groups, although there was a trend toward superiority
of group III relative to group II. Identical scores were seen
regarding emotional role (Table 2). In mental health, group I
scored better than group II (P ¼ .054), and the difference
between groups III and II was also significant (63.4 vs
73.23, respectively, P ¼ .016). Similar findings were
made after correction for follow-up, although only the infe-
riority of mechanical replacement relative to the autograft
remained significant (P ¼ .018).TABLE 2. Valve-specific questions as proposed by Perchinsky and colleag
SF-36 subscales Group I P value I vs II Grou
Physical functioning 88.39  16.21 .022 80.37 
Role physical 75.28  34.2 .960 75.6 
Bodily pain 81.04  23.28 .057 72.4 
General health 66.21  20.19 .029 57.67 
Vitality 58.82  19.58 .057 51.53 
Social functioning 83.67  18.5 .184 79.43 
Role emotional 80.84  32.0 .392 75.0 
Mental health 70.07  17.75 .054 63.4 
SF-36,German version of the Short FormHealth Survey;Group I, patients with valve repair
Ross procedure.
The Journal of Thoracic and CaAnxiety and Depression (Hospital Anxiety and
Depression Scale, Cardiac Anxiety Questionnaire)
No differences were found between the groups with re-
gard to anxiety and depression in the Hospital Anxiety
and Depression Scale score (Table 3), either in the whole
cohort or in the subgroup of 3 to 7 years of follow-up. Rel-
ative to age-corrected published data for healthy subjects
(23), anxiety scores were higher than normal in groups I
(P ¼ .04) and II (P ¼ .025), whereas the group III score
was not significantly different from normal (P ¼.134).
With regard to depression, group I scored lower than age-
matched healthy subjects (23, P¼ .038), whereas the differ-
ences between groups II and III and healthy control subjects
were not significant or only borderline significant (P¼ .193
and P ¼ .055, respectively).
In the Cardiac Anxiety Questionnaire, group II expressed
significantly more fear than group III, whereas group I
showed intermediate scores (Table 3). With respect to
heart-focused attention, groups I and III exhibited statisti-
cally identical scores that were better than the group II score
(P ¼ .043 and P ¼ .053, respectively; Table 3). There were
no significant differences in avoidance (Table 3). The differ-
ences were not significant after correction for follow-up.
Our patients were different from published healthy con-
trol subjects in exhibiting higher fear (group II, 1.67;
P¼ .008), lower avoidance (1.21, P ¼ .005), and higher at-
tention (1.52, P ¼ .034). With regard to Cardiac Anxiety
Questionnaire scores, they were similar to other patients
who had undergone valve replacement or coronary bypass
surgery, with more anxiety but less avoidance.22
With regard to the valve-specific questionnaire, there
were no differences between the groups on question 1 (pos-
itive view of the decision to have undergone surgery,
P ¼ .821; Table 4). As expected, patients in group II were
more frequently disturbed by valve sounds. Interestingly,
8.4% in group I and 7.7% in group III noted subjective dis-
turbance by valve sounds (P ¼ .000). Patients in group II
more frequently felt disturbed by follow up visits and blood
tests than did those in groups I and III (P ¼ .011). There
were no differences among the 3 groups in concern regard-
ing possible complications related to the valve operationues13 handed out as questionnaire
p II P value II vs III Group III P value I vs III
19.59 .594 82.56  20.77 .099
36.02 .684 78.84  36.06 .599
26.58 .180 79.82  24.84 .739
21.74 .118 64.86  18.34 .733
20.55 .049 60.38  18.93 .682
22.46 .093 86.21  22.35 .522
39.04 .979 75.21  39.52 .413
18.26 .016 73.23  17.79 .362
;Group II, patients after mechanical aortic valve replacement;Group III, patients after
rdiovascular Surgery c Volume 142, Number 2 e21
FIGURE 1. Mean physical sum scores at follow-up in patients with valve
repair (group I), patients after mechanical aortic valve replacement (group
II), and patients after the Ross procedure (group III).
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lation was rarely a concern in groups I and III, whereas it
was frequent in group II (P ¼ .000; Table 4). There was
a significant difference in the fear of valve failure, with pa-
tients in group II more frequently afraid than those in groups
I and III (P ¼ .036). With regard to the fear of requiring
a repeat operation, the groups were comparable (P ¼ .382).DISCUSSION
QoL achieved by therapeutic procedures has been receiv-
ing more attention in the last 10 years. Several studies have
compared aortic valve replacement with mechanical versus
biologic prostheses.12,13 The conclusion of these studies
was that there was no significant difference between the
2 different types of valves, despite the need for
anticoagulation after mechanical replacement. Those
results stand in contrast to the findings of N€otzold and
coworkers,14 who compared QoL after pulmonary autograft
implantation with that after mechanical valve replacement.
N€otzold and coworkers14 found significantly higher scores
in physical and mental items of the SF-36, which theyTABLE 3. Means and SDs of German version of the Short Form Health S
SF-36 subscales Group I P value I vs II Group
Hospital Anxiety and Depression Scale subscales
Anxiety 5.69  4.01 .841 6.75  5
Depression 3.69  3.25 .814 3.70  3
Cardiac Anxiety Questionnaire subscales
Fear 1.32  0.88 .153 1.68  0
Avoidance 0.80  0.86 .264 1.16  0
Attention 1.03  0.65 .081 1.38  0
P values are results of analysis of variance. Group I, Patients with valve repair; Group I
procedure.
e22 The Journal of Thoracic and Cardiovascular Surgattributed in part to the absence of anticoagulation after
pulmonary autograft implantation. The evidence, however,
is less clear at a second look. The same authors published
another investigation,22 in which the QoL score parameters
were similar between pulmonary autograft implantation
and mechanical aortic valve replacement with self-
controlled anticoagulation.
We found similar scores in SF-36 parameters for all 3 in-
vestigated therapeutic options. QoL after all 3 was generally
comparable to that published for healthy control subjects19
and to data published for recovery after valve replacement
and coronary bypass surgery.23 Interestingly, our patients
scored lower in symptoms of general depression than did
age-matched healthy control subjects.24 This difference
was significant for the patients who had undergone aortic
valve reconstruction. We have also observed this phenome-
non after other cardiovascular operations. It is probably re-
lated to positive readjustment of the patient after having
successfully coped with a major life event, such as a cardiac
operation. As expected, both general and cardiac-related
levels of anxiety were increased relative to published norms.
This can easily be explained by the fact that all our patients
by definition had undergone the realization of vulnerability,
the fact of having a life-threatening cardiac disease. It may
be seen as a positive coping strategy for facing life after
a valve operation, in which attention and awareness will
lead to better compliance with follow up and medical rec-
ommendations. Nevertheless, QoL and heart-related anxi-
ety as measured in this study were not as much influenced
by the type of operation as we had expected.
We did, however, find some differences, mainly between
mechanical valve replacement versus repair or autograft. In
general, patients with mechanical valve substitutes scored
lower than did those after repair or pulmonary autograft im-
plantation. These differences were not always significant,
but the trend was consistent. We can confirm the findings of
N€otzold and coworkers14 and can extend them to repair.
Thus our working hypothesis—that patients intuitively ap-
preciate theabsenceofanticoagulationandavoidanceofa for-
eign body, resulting in higherQoL—appears to be confirmed.
On the other hand, there were some differences between
a previous investigation14 and our own. As a trend, oururvey subscales
II P value II vs III Group III P value I vs III
.07 .258 4.90  3.82 .324
.51 .265 2.76  2.98 .161
.91 .059 1.14  0.73 .571
.79 .542 0.88  1.11 .627
.89 .303 1.19  0.79 .500
I, patients after mechanical aortic valve replacement; Group III, patients after Ross
ery c August 2011
TABLE 4. Means and standard deviations of Hospital Anxiety and
Depression Scale subscales and items
Valve-specific
questions
Group
I
Group
II
Group
III
P
value
1. If I had to do it over again, would I make the same decision to have
surgery?
Yes 94.0% 89.7% 100.0% .821
I don’t know 3.6% 7.7% 0.0%
No 2.4% 2.6% 0.0%
2. Is there a valve sound that bothers me?
Never/rarely 91.5% 41.0% 92.4% <.001
Occasionally 6.1% 33.3% 5.1%
Frequently/always 2.4% 25.7% 2.5%
3. Following my valve surgery, the frequency of doctor visits and blood
tests bothers me.
Never/rarely 75.9% 61.6% 84.2% .011
Occasionally 20.5% 17.9% 13.2%
Frequently/always 3.6% 20.5% 2.6%
4. The possibility of complications due to my implanted valve concernsme.
Never/rarely 48.2% 48.7% 61.5% .309
Occasionally 43.4% 30.8% 33.3%
Frequently/always 8.4% 20.5% 5.2%
5. I am concerned about possible bleeding caused by my anticoagulant
medication.
Never/rarely 80.5% 43.6% 79.5% <.001
Occasionally 12.2% 15.4% 7.7%
Frequently/always 7.3% 41.0% 12.8%
6. I am afraid that my valve may fail.
Never/rarely 53.7% 51.3% 76.9% .036
Occasionally 34.1% 28.2% 17.9%
Frequently/always 12.2% 20.5% 5.2%
7. I am afraid that I may need another valve operation.
Never/rarely 38.0% 48.7% 53.8% .382
Occasionally 45.0% 25.6% 25.6%
Frequently/always 17.0% 25.7% 20.6%
P values are results of analysis of variance.Group I, Patients with valve repair;Group
II, patients after mechanical aortic valve replacement; Group III, patients after Ross
procedure.
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scores than in the previous study, whereas our patients after
pulmonary autograft implantation scored lower. The rea-
sons for these differences are not clear. One reason may
be a difference in patient age; our patients were by selection
younger than those studied previously.14 There is also
a methodologic difference between our study and those of
N€otzold and coworkers.14 They had assessed QoL through
an interview according to SF-36, whereas we handed out
the questionnaires to be returned later. A personal interview
may be able to ‘‘sharpen’’ the questionnaire by modifying
wordings to meet the needs of the interviewee. On the other
hand, the same process may also lead to bias and skewed
results. In view of the fact that the validating studies of
the SF-36 form included filling out a questionnaire by the
patient without interference from an interviewer, we de-
cided to follow the validated procedure. We cannot, how-The Journal of Thoracic and Caever, rule out that misinterpretation of questions may have
influenced the results.
The results of the valve-specific questionnaire were as
expected and can possibly explain the differences in QoL
as assessed by the SF-36. As expected, patients after me-
chanical aortic valve replacement more frequently reported
being bothered by valve sounds, follow-up visits, fear of
valve-related complications, and fear of anticoagulation-
related bleeding.
We did observe some unexpected findings from the
valve-specific questions. Completely unexpected was the
result that approximately 8% each in the repair and auto-
graft groups reported that they were bothered by valve
sounds. The reason can only be speculative, but possibly
these patients exhibited a high degree of attention to their
heart function postoperatively. Another surprising finding
was that 20% of the well-informed patients were afraid of
possible failure of their mechanical valve, whereas this
fear was found in only 12% of patients in the repair group
and 5% of those in the autograft group. This is in strong
contrast to the information given preoperatively at the
time of informed consent, when the mechanical valve was
described as having an excellent 40-year durability. Also
surprising was the fear of a second operation, which was
similar among the 3 groups, even though all were informed
preoperatively that mechanical replacement was the option
with the least long-term likelihood of repeat surgery. A pos-
sible explanation may be that the coping process after
having undergone aortic valve surgery involves not only ra-
tional but also emotional components. In patients without
a mechanical valve, anxiety may be projected into sensa-
tions involving the heart, which are misinterpreted as
disturbing valve sounds. Patients with a mechanical valve
could project their anxiety into fear of failure, despite ratio-
nally knowing otherwise. It remains to be clarified whether
patients with these unexpected reactions exhibit more
pronounced psychopathology, such as anxiety.
The results of any investigation dealing with QoL and
distress after an acute event may also be influenced by du-
ration of follow-up as an indicator of time since the opera-
tion. We found that in the first 6 to 18 months, there was
a trend for patients to express higher levels of anxiety and
concerns. This leveled off at 1.5 to 2 years. For this reason,
we repeated the calculations for a cohort of patients with
a more defined postoperative interval. A more exact deter-
mination of time-related changes would require a longitudi-
nal comparison of the different treatment methods.
Finally, the diagnostic limitations of questionnaires also
must be considered. The questions are not always under-
stood by all individuals in identical fashion, and a question-
naire is not able to assess the effects of personality and
individual expectations of the individual. To detect subtle
effects, such as those induced by expectation or by the in-
formed consent, qualitative interviews would be necessary.rdiovascular Surgery c Volume 142, Number 2 e23
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DThere are several limitations to our current investigation.
This was not a randomized study, but rather a retrospective
cross-sectional study. The preoperative condition varied
among the groups, with a higher proportion of advanced ac-
ademic education also seen in the repair group. This may
have led to a selection bias in that patients undergoing repair
had different psychologic profiles and a higher level of pre-
operative information. A bias through the way the informed
consent was obtained cannot be ruled out, although we tried
to present the same information to every patient. The patient
cohorts were relatively small in relation to the expected var-
iability in psychologic profiles. Finally, we are studying the
attitude of patients toward anticoagulation in general in an
ongoing research project, and there seem to be marked dif-
ferences despite the same information level. This was not
assessed at the time of this study. Future studies should
take these aspects into consideration.
In conclusion, all 3 investigated surgical methods led to
excellent QoL and limited changes in anxiety and depres-
sion relative to published data on healthy control subjects.
Interestingly, the level of depression was lower than age-
matched published norms for all groups. Both aortic valve
reconstruction and replacement with a pulmonary autograft
resulted in a lesser degree of postoperative subjective distur-
bance. Further research will be needed to clarify possible
reasons for the observed differences.References
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